ConductScience.org, home

Paper37066

Bromocriptine in the treatment of parkinsonism.

Parkes JD. Drugs, 1979. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bromocriptine in the treatment of parkinsonism. Papers, record 37066. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37066

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bromocriptine in the treatment of parkinsonism.
PubMed
Journal
Drugs
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.75
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parkes JDJ D

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BromocriptineMajor topic
Parkinson DiseaseMajor topic
Apomorphine
Catecholamines
Drug Interactions
Ergolines
Humans
Kinetics
Motor Activity
Movement Disorders
Piribedil
Receptors, Drug
Stereotyped Behavior

Source PubMed

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
173,828Digital vasospasm with bromocriptine.Lancet1976https://conductscience.org/library/papers/73828PubMed
24,143,315Treatment of parkinsonism with bromocriptine.Lancet1974https://conductscience.org/library/papers/4143315PubMed
3166,332Studies on the antiparkinsonism efficacy of lergotrile.Neurology1975https://conductscience.org/library/papers/166332PubMed
4333,855Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.Acta Neurol Scand1977https://conductscience.org/library/papers/333855PubMed
54,911,257Oral L-dopa treatment of parkinsonism.Acta Med Scand1970https://conductscience.org/library/papers/4911257PubMed
6907,536Brain dopamine turnover and the relief of parkinsonism.Arch Neurol1977https://conductscience.org/library/papers/907536PubMed
7786,607Metoclopramide: a review of its pharmacological properties and clinical use.Drugs1976https://conductscience.org/library/papers/786607PubMed
88,619Apomorphine as an antagonist of the dopamine response from the nucleus accumbens.J Pharm Pharmacol1976https://conductscience.org/library/papers/8619PubMed
9989,885Treatment of parkinson's disease with bromocriptine.N Engl J Med1976https://conductscience.org/library/papers/989885PubMed
1074,475Lergotrile in Parkinson's disease.Lancet1976https://conductscience.org/library/papers/74475PubMed
11577,309Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.Pharmacol Res Commun1977https://conductscience.org/library/papers/577309PubMed
121,107,835Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.N Engl J Med1976https://conductscience.org/library/papers/1107835PubMed
13330,825Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.J Neurol Neurosurg Psychiatry1977https://conductscience.org/library/papers/330825PubMed
14817,221The antiparkinsonian efficacy of bromocriptine.Neurology1976https://conductscience.org/library/papers/817221PubMed
154,146,398Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.J Pharm Pharmacol1973https://conductscience.org/library/papers/4146398PubMed
161,238,569Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines.J Med Chem1975https://conductscience.org/library/papers/1238569PubMed
17578,000Treatment of Parkinson's disease with bromocriptine.N Engl J Med1977https://conductscience.org/library/papers/578000PubMed
1876,754Drugs for Parkinson's disease.Lancet1978https://conductscience.org/library/papers/76754PubMed
19773,080Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.Acta Neurol Scand1976https://conductscience.org/library/papers/773080PubMed
20183,071Effects of bromocriptine on central dopaminergic receptors.Life Sci1976https://conductscience.org/library/papers/183071PubMed

See all 57 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
10,146,952Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's disease.Pharmacoeconomics1992https://conductscience.org/library/papers/10146952PubMed
6,452,152Assessment of extrapyramidal disorders.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6452152PubMed
6,188,812Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.J Neurol1982https://conductscience.org/library/papers/6188812PubMed
2,647,907The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.J Neurol Neurosurg Psychiatry1989https://conductscience.org/library/papers/2647907PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37066

GET https://conductscience.org/api/papers/v1/37066/references?page=2